Unlike COAD, we observed a consistent relationship between elevated SMARCA1 expression and poor prognosis of STAD across the different databases which indicates that SMARCA1 might be an independent risk factor for STAD. This evidence concerns the gene SMARCA1 and gastric adenocarcinoma.